Checkpoint Therapeutics Inc (NASDAQ:CKPT)

3.21
BATS BZX Real-Time Price
As of 2:42pm ET
 +0.05 / +1.58%
Today’s Change
2.16
Today|||52-Week Range
5.38
+21.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$259.8M

Company Description

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in New York, NY.

Contact Information

Checkpoint Therapeutics, Inc.
2 Gansevoort Street
New York New York 10014
P:(781) 652-4500
Investor Relations:

Employees

Shareholders

Individual stakeholders8.56%
Other institutional8.50%
Mutual fund holders4.71%

Top Executives

James F. OlivieroPresident, Chief Executive Officer & Director
William Garrett GrayChief Financial Officer, Secretary & Treasurer
Jaclyn JaffeInvestor Relations Contact